BioWorld Asia

Jan. 25, 2006

SkyePharma Still Tumultuous, As Gowrie-Smith Resigns Post

LONDON - The battle for SkyePharma plc moved into war when founder Ian Gowrie-Smith resigned to forestall an attempt by activist shareholders to oust him. (BioWorld International) Read More

Lipoxen Goes Public Through Merger With Shell Greenchip

Yeast Proteome Survey Details Approach To Molecular Function

EuroGen Drops European Application For Orathecin

DBV Technologies Raises EUR12M In Second Round

Amgen Plans To Build $1B Biologics Facility In Ireland

Syntonix, Biovitrum In Deal On Long-Acting Clotting Product

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 22, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.